Cytokinetics, Incorporated (CYTK) vs Krystal Biotech, Inc. (KRYS)
Cytokinetics, Incorporated and Krystal Biotech, Inc. are both Biotechnology companies. Krystal Biotech, Inc. is the larger, with a market value of $10.2B against $9.0B — 1.1× the size. Cytokinetics, Incorporated has negative trailing earnings, so its P/E is not meaningful; Krystal Biotech, Inc. trades at 41.9×. Krystal Biotech, Inc. grew revenue faster over the last twelve months: 22.6% against −21.1%. Krystal Biotech, Inc. has the higher net margin (54.8% vs −1,321.1%) and the higher return on invested capital (24.1% vs 0.00%). Across the 16 metrics below, Krystal Biotech, Inc. leads on 14 and Cytokinetics, Incorporated on 2.
Valuation
Profitability
| Metric | CYTK | KRYS | Biotechnology median |
|---|---|---|---|
| Gross margin | 87.97% | 94.64% | 65.16% |
| Operating margin | (1,046.12%) | 44.89% | 0.00% |
| Net margin | (1,321.12%) | 54.82% | 0.00% |
| Free cash flow margin | (858.16%) | 58.52% | 0.00% |
| Return on equity | 329.76% | 20.12% | (57.72%) |
| Return on assets | (56.76%) | 18.30% | (49.22%) |
| Return on invested capital | 0.00% | 24.07% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack